Disparity in Incidence and Health Outcomes between Rural and Urban Patients with Alzheimers disease and related disorders
城乡阿尔茨海默病及相关疾病患者的发病率和健康结果差异
基本信息
- 批准号:9225408
- 负责人:
- 金额:$ 8.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAgeAlzheimer&aposs DiseaseCaringCessation of lifeCommunitiesDataDecision MakingDevelopmentDiagnosisDiagnosticDiseaseEducation and OutreachElderlyEnrollmentEnsureEthnic OriginEvidence based practiceFamilyFamily memberFee-for-Service PlansFutureGenderGoalsHealthHealth PersonnelHealth ServicesHealth Services AccessibilityHealth systemHealthcareHome Care ServicesHospitalizationImprove AccessIncidenceInterventionKnowledgeLife ExpectancyLinkMeasuresMedicareMedicare claimMethodsNursing HomesOlder PopulationOutcomePatientsPhysiciansPoliciesPolicy DevelopmentsPolicy MakerPopulationPopulation StudyPrevalenceProspective cohort studyProviderRaceResearchRisk FactorsRuralRural CommunityRural HealthRural PopulationScientistServicesSurveysSystemTimeVisiting NurseWorkaccurate diagnosisadverse outcomebasebeneficiaryburden of illnesscare deliveryclinical practicedesignevidence baseexperiencehealth care qualityhealth care service utilizationhealth disparityhealthcare acceptabilityhuman old age (65+)improvedinsightmedical specialtiesmeetingsmortalityresidencerural arearural settingscreeningurban areaurban disparity
项目摘要
ABSTRACT
By 2030, over 20% of the US population will be at least 65 years old, the age at which incidence of
Alzheimer's disease and related disorders (ADRD) begins to increase. In 2014, 17% of the population living in
rural areas was already over the age of 65, suggesting that rural populations may be disproportionally affected
by ADRD in current and coming years. There is growing evidence that disparities in disease burden as well as
availability, accessibility, affordability, and acceptability of health services exist among older adults living in
rural areas, likely contributing to the growing gap in life expectancy witnessed between urban and rural
communities. Previous studies have found that ADRD prevalence rates vary by gender, race, and ethnicity, yet
few studies have examined disparities in diagnosis and outcomes of older adults living in urban and rural
areas. Studies that have examined rural health disparities related to ADRD have largely focused on issues
related to access to care, and suggest that ADRD patients in rural areas are more likely to receive suboptimal
healthcare. There is a gap in our knowledge on how place of residence influences diagnosis and subsequent
outcomes of older adults with ADRD. Understanding if disparities exist for older adults with ADRD living in rural
areas could yield important insights into the risk factors for ADRD, the variables influencing the experience of
living with ADRD, and the methods by which they can be more effectively managed. The objective of this
application, the first step toward this long-term goal, is to conduct a population based study and thorough
analysis to identify if rural-urban disparities in the diagnostic incidence and prevalence of ADRD, healthcare
utilization, and health outcomes exist. The central hypothesis of this proposal is that rural Medicare
beneficiaries with ADRD will be diagnosed later in the course of their disease and experience worse health
outcomes. This hypothesis is based on preliminary work that shows the prevalence rate of ADRD is lower, yet
the mortality rate due to ADRD is higher in states with a higher share of its population living in rural areas. To
achieve this objective, we propose two aims. First, we will compare the diagnostic incidence and prevalence of
ADRD between Medicare beneficiaries living in rural and urban communities. Second, we will compare survival
and trajectories of acute, nursing home and home health care use in six years following the initial diagnosis of
ADRD between rural and urban beneficiaries. We propose to study fee-for-service Medicare beneficiaries in
2008-2015 integrating Medicare enrollment, claims, and resident assessment data. Findings of this study have
several expected benefits for many. For policy makers, this research will enable evidence-based policy
development aimed at improving rural health care. For rural health providers, this work will drive efforts to
improve ADRD screening in order to ensure rural beneficiaries receive a timely diagnosis, which may delay
future adverse outcomes. For rural health systems, these findings will help plan for future demand and
understand gaps in our current system in meeting this population's needs.
抽象的
到 2030 年,超过 20% 的美国人口将至少 65 岁,即该年龄
阿尔茨海默病及相关疾病 (ADRD) 开始增加。 2014年,17%的人口居住在
农村地区的老年人已经超过 65 岁,这表明农村人口可能受到不成比例的影响
ADRD 在当前和未来几年。越来越多的证据表明,疾病负担和疾病负担方面存在差异
居住在以下地区的老年人对医疗服务的可获得性、可及性、可负担性和可接受性
农村地区,可能导致城乡之间预期寿命差距不断扩大
社区。先前的研究发现 ADRD 患病率因性别、种族和民族而异,但
很少有研究考察城市和农村老年人的诊断和结果差异
地区。研究与 ADRD 相关的农村健康差异的研究主要集中在问题上
与获得护理的机会有关,并表明农村地区的 ADRD 患者更有可能接受次优的治疗
卫生保健。我们对居住地如何影响诊断和后续治疗的认识存在差距
患有 ADRD 的老年人的结果。了解生活在农村的患有 ADRD 的老年人是否存在差异
这些领域可以对 ADRD 的风险因素、影响 ADRD 经历的变量产生重要的见解。
患有ADRD,以及更有效地管理它们的方法。此举的目的
应用程序是实现这一长期目标的第一步,是进行基于人群的研究并进行彻底的研究
分析以确定 ADRD、医疗保健的诊断发生率和患病率是否存在城乡差异
利用率和健康结果是存在的。该提案的中心假设是农村医疗保险
患有 ADRD 的受益人将在病程后期被诊断出来,并且健康状况会更差
结果。该假设基于初步研究,该研究表明 ADRD 的患病率较低,但
在农村地区人口比例较高的州,ADRD 导致的死亡率较高。到
为了实现这一目标,我们提出两个目标。首先,我们将比较诊断发生率和患病率
居住在农村和城市社区的医疗保险受益人之间的 ADRD。其次,我们将比较生存率
初步诊断后六年内急性病、疗养院和家庭医疗保健的使用轨迹
农村和城市受益人之间的 ADRD。我们建议研究按服务收费的医疗保险受益人
整合 2008-2015 年医疗保险登记、索赔和居民评估数据。这项研究的结果有
对许多人来说有几个预期的好处。对于政策制定者来说,这项研究将使基于证据的政策成为可能
发展目标是改善农村医疗保健。对于农村卫生服务提供者来说,这项工作将推动努力
改善 ADRD 筛查,以确保农村受益人及时得到诊断,这可能会延误
未来的不良后果。对于农村卫生系统来说,这些发现将有助于规划未来的需求和
了解我们当前系统在满足这一人群需求方面的差距。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Md Momotazur Rahman其他文献
Md Momotazur Rahman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Md Momotazur Rahman', 18)}}的其他基金
Private Equity Expansion in Assisted Living: Implications for Dementia Care
私募股权在辅助生活领域的扩张:对痴呆症护理的影响
- 批准号:
10738928 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
The Impact of Advanced Practice Clinicians on End of Life Outcomes for Older Adults with Dementia
高级实践临床医生对痴呆症老年人临终结局的影响
- 批准号:
10341076 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 8.13万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 8.13万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 8.13万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 8.13万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 8.13万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 8.13万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 8.13万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




